Method for Manufacturing Useful Substance

US2016130618A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016130618-A1
Application numberUS-201614990047-A
CountryUS
Kind codeA1
Filing dateJan 7, 2016
Priority dateJul 9, 2013
Publication dateMay 12, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for producing an objective substance is provided. An objective substance is produced by culturing a microorganism which has been modified so that the activity of a dicarboxylic acid exporter protein is reduced in a medium, and collecting the objective substance from the medium.

First claim

Opening claim text (preview).

1 . A method for producing an objective substance, the method comprising: culturing a microorganism having an objective substance-producing ability in a medium to produce and accumulate the objective substance in the medium or in cells of the microorganism; and collecting the objective substance from the medium or the cells, wherein the microorganism has been modified so that the activity of a dicarboxylic acid exporter protein is reduced. 2 . The method according to claim 1 , wherein the activity of the dicarboxylic acid exporter protein is reduced by attenuating the expression of a gene encoding the dicarboxylic acid exporter protein or by deleting the gene. 3 . The method according to claim 2 , wherein the gene encoding the dicarboxylic acid exporter protein is selected from the group consisting of yjjP gene, yjjB gene, yeeA gene, ynfM gene, sucE1 gene, and combinations thereof. 4 . The method according to claim 3 , wherein the yjjP gene is a DNA selected from the group consisting of: (A) a DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 158 or 160; (B) a DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 158 or 160, but including substitution, deletion, insertion, or addition of one or several amino acid residues, the protein having an activity to export a dicarboxylic acid; (C) a DNA comprising the nucleotide sequence of SEQ ID NO: 157 or 159; and (D) a DNA able to hybridize under stringent conditions with a nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO: 157 or 159, or with a probe that can be prepared from the complementary nucleotide sequence, and encoding a protein having an activity to export a dicarboxylic acid. 5 . The method according to claim 3 , wherein the yjjB gene is a DNA selected from the group consisting of: (A) DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 162 or 164; (B) DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 162 or 164, but including substitution, deletion, insertion, or addition of one or several amino acid residues, the protein having an activity to export a dicarboxylic acid; (C) DNA comprising the nucleotide sequence of SEQ ID NO: 161 or 163; and (D) DNA able to hybridize under stringent conditions with a nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO: 161 or 163, or with a probe that can be prepared from the complementary nucleotide sequence, and encoding a protein having an activity to export a dicarboxylic acid. 6 . The method according to claim 3 , wherein the yeeA gene is a DNA selected from the group consisting of: (A) DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 166, 168, or 170; (B) DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 166, 168, or 170, but including substitution, deletion, insertion, or addition of one or several amino acid residues, the protein having an activity to export a dicarboxylic acid; (C) DNA comprising the nucleotide sequence of SEQ ID NO: 165, 167, or 169; and (D) DNA able to hybridize under stringent conditions with a nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO: 165, 167, or 169, or with a probe that can be prepared from the complementary nucleotide sequence, and encoding a protein having an activity to export a dicarboxylic acid. 7 . The method according to claim 3 , wherein the ynfM gene is a DNA selected from the group consisting of: (A) DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 172, 174, 176, 178, or 180; (B) DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 172, 174, 176, 178, or 180, but including substitution, deletion, insertion, or addition of one or several amino acid residues, the protein having an activity to export a dicarboxylic acid; (C) DNA comprising the nucleotide sequence of SEQ ID NO: 171, 173, 175, 177, or 179; and (D) DNA able to hybridize under stringent conditions with a nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO: 171, 173, 175, 177, or 179, or with a probe that can be prepared from the complementary nucleotide sequence, and encoding a protein having an activity to export a dicarboxylic acid. 8 . The method according to claim 3 , wherein the sucE1 gene is a DNA selected from the group consisting of: (A) DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 278 or 280; (B) DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 278 or 280, but including substitution, deletion, insertion, or addition of one or several amino acid residues, the protein having an activity to export a dicarboxylic acid; (C) DNA comprising the nucleotide sequence of SEQ ID NO: 277 or 279; and (D) DNA able to hybridize under stringent conditions with a nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO: 277 or 279, or with a probe that can be prepared from the complementary nucleotide sequence, and encoding a protein having an activity to export a dicarboxylic acid. 9 . The method according to claim 1 , wherein the objective substance is a metabolite derived from acetyl-CoA and/or an L-amino acid. 10 . The method according to claim 9 , wherein the metabolite derived from acetyl-CoA and/or the L-amino acid is selected from the group consisting of isopropyl alcohol, ethanol, acetone, propylene, isoprene, 1,3-butanediol, 1,4-butanediol, 1-propanol, 1,3-propanediol, 1,2-propanediol, ethylene glycol, isobutanol, and combinations thereof. 11 . The method according to claim 9 , wherein the metabolite derived from acetyl-CoA and/or the L-amino acid is selected from the group consisting of citric acid, itaconic acid, acetic acid, butyric acid, 3-hydroxybutyric acid, polyhydroxybutyric acid, 3-hydroxyisobutyric acid, 3-aminoisobutyric acid, 2-hydroxyisobutyric acid, methacrylic acid, 6-aminocaproic acid, and combinations thereof. 12 . The method according to claim 9 , wherein the metabolite derived from acetyl-CoA and/or the L-amino acid is selected from the group consisting of polyglutamic acid, L-glutamic acid, L-glutamine, L-arginine, L-ornithine, L-citrulline, L-leucine, L-isoleucine, L-valine, L-cysteine, L-serine, L-proline, and combinations thereof. 13 . The method according to claim 12 , wherein the L-glutamic acid is monoammonium L-glutamate or monosodium L-glutamate. 14 . The method according to claim 1 , wherein the microorganism is a coryneform bacterium or a bacterium belonging to the family Enterobacteriaceae. 15 . The method according to claim 14 , wherein the coryneform bacterium is Corynebacterium glutamicum. 16 . The method according to claim 14 , wherein the bacterium belonging to the family Enterobacteriaceae is Escherichia coli, Pantoea ananatis , or Enterobacter aerogenes. 17 . The method according to claim 1 , wherein the dicarboxylic acid is selected from the group consisting of malic acid, succinic acid, fumaric acid, 2-hydroxyglutaric acid, and α-ketoglutaric acid. 18 . The method according to claim 1 , wherein the microorganism has been further modified so that malyl-CoA-producing ability is increased. 19 . The method according to claim 1 , wherein the microorganism has been further modified so that α-ketoglutarate synthase activity is increased.

Assignees

Inventors

Classifications

  • Alpha- or beta- amino acids {(other amino acids C12P13/005)} · CPC title

  • C12P13/14Primary

    Glutamic acid; Glutamine · CPC title

  • Amines; Imines · CPC title

  • Preparation of oxygen-containing organic compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016130618A1 cover?
A method for producing an objective substance is provided. An objective substance is produced by culturing a microorganism which has been modified so that the activity of a dicarboxylic acid exporter protein is reduced in a medium, and collecting the objective substance from the medium.
Who is the assignee on this patent?
Ajinomoto Kk
What technology area does this patent fall under?
Primary CPC classification C12P13/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu May 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).